Barclays »

Generate Biomedicines Ord shares owned by Barclays

Quarter-by-quarter ownership of Generate Biomedicines Ord shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Barclays

Quarter filed Position value Share count Share price at filing
2026-03-31 $886k 71k 12.50

More positions owned by Barclays

Ishares Tr Opt Put Option (EEM)
Microsoft Corporation (MSFT)
STATE STR SPDR S&ampP 500 ETF T Opt Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Opt Call Option (QQQ)
Ishares Tr Fund (IWM)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ishares Tr Opt Put Option (HYG)
JPMORGAN CHASE &amp Opt Call Option (JPM)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
FMR
Capital World Investors
Braidwell
Arch Venture Corp
HarbourVest Partners
Baker Bros. Advisors
Harvard Management Company
Nvidia Corp
Alyeska Investment Group
ARK Investment Management
Millennium Management
UBS Group
Affinity Asset Advisors
Morgan Stanley

View all funds holding Generate Biomedicines Ord